Janssen gets FDA nod for type 2 diabetes drug

04/1/2013 | HealthDay News

The FDA has granted Janssen Pharmaceuticals approval for its type 2 diabetes drug Invokana. The drug, a sodium-glucose co-transporter 2 inhibitor, was the first of its class to gain federal approval.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Director, Health Plan Operations
Group Health Cooperative
Seattle, WA
Counsel II, Legal (Anti-corruption)
Gilead Sciences
Foster City, CA
Vice President, Idaho Regional Director
Boise, ID